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Previewscould be purged by pharmacological
manipulations, combining HAART with
agents aimed at forcing viral expression
(reviewed in Trono et al., 2010). With
primarily a T lymphocyte-based latent
reservoir in mind, various combinations
of T cell activators, inhibitors of histone-
modifying enzymes, and blockers of
DNA methylation have been tested.
However, there is little evidence so far
that latently infected, resting CD4+
T cells were destroyed upon exposure to
purging agents or that relapses that are
almost systematically observed upon
HAART cessation could be prevented. If
an HSC-based reservoir is a functionally
relevant source of virus contributing to
this rebound, this is no surprise, as the
listed agentsmay have little effect on virus
residing in this other reservoir.
One prediction of Carter et al.’s data is
that HIV isolates reactivated by cytokine
treatment of HSCs purified from the
bone marrow of HIV-infected individuals
should exhibit an X4 or a dual X4/R5
tropism. A clinically essential corollary is
that only patients in whom the R5-to-X4172 Cell Host & Microbe 9, March 17, 2011 ªswitch has already taken place should
harbor HIV-infected HSC. Finally, in such
patients, if HAART was interrupted after
long aviremic periods, the rebounding
viruses should include X4-tropic strains.
These points warrant investigation.
Indeed, if they were verified, it would
imply that the establishment of a theoreti-
cally inexpugnable latent reservoir in mul-
tipotent HSCs occurs only relatively late in
the course of HIV infection. Accordingly, it
should be preventable by the early instau-
ration of HAART. This would add to the list
of arguments in favor of a therapeutic
attitude already advocated to minimize
the size of the global latent reservoir and
the amount of damage inflicted on the
immune system, particularly in the gut,
during the early times of infection
(Brenchley et al., 2006). Whether this
might open the door to HIV eradication
remains an open question.REFERENCES
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HIV-1 engages the cellular ESCRT-III/VPS4 membrane scission machinery for its escape from host cells.
Three papers now begin to demystify its mode of action by showing that HIV-1 requires only the transient
recruitment of a surprisingly small subset of ESCRT-III components, whose membrane abscission function
depends on VPS4 activity.TheESCRTpathway consists of a network
of protein complexes (ESCRT-0 to -III) and
of associated proteins such as VPS4 and
ALIX. ESCRT complexes are recruited
during diverse cellular processes ranging
from multivesicular body (MVB) biogen-
esis and cytokinesis to the budding of
some enveloped viruses, such as HIV-1
(Bieniasz, 2006; Hurley and Hanson,
2010; Peel et al., 2010; Saksena et al.,2007). All these processes ultimately
depend on the scission of membrane
necks with an unusual topology, which is
carried out by ESCRT-III (Hurley and
Hanson, 2010).
ESCRT-III assembles from monomeric
cytosolic subunits, producing mem-
brane-associated helical filaments. The
assembly of such filaments within bud
necks is thought to induce membraneconstriction, eventually leading to mem-
brane fission (Peel et al., 2010). Interest-
ingly, ESCRT-III subunits can assemble
into helical tubules with dome-like caps
(Lata et al., 2008), suggesting that
membrane scission could ultimately be
driven by ESCRT-III domes that narrow
bud necks from their cytosolic side until
spontaneous fission occurs (Peel et al.,
2010).
Figure 1. Model of ESCRT-III/VPS4 Function in HIV-1 Release
ESCRT-III CHMP4 and CHMP2 members as well as VPS4 dodecamers are
recruited transiently to budding sites after completion of Gag assembly at
the plasmamembrane. CHMP4 and CHMP2 interact and potentially assemble
into filamentous spiral structures that adopt a dome-like shape, lining the
inside of the membranous neck that connects the newly formed virus particle
and the plasma membrane. Spontaneous fission is then induced by VPS4
ATPase activity modulating the ESCRT-III dome, which leads to virion release.
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PreviewsTheESCRT-III complexhas
four structurally related core
subunits, which assemble
sequentially. These are called
Vps20, Snf7, Vps24, and
Vps2 in yeast and CHMP6,
CHMP4A-C, CHMP3, and
CHMP2A-B in humans (Sak-
sena et al., 2007). Vps20
(CHMP6) binds to mem-
branes and nucleates the
polymerization of Snf7
(CHMP4A-C) within bud
necks, while Vps24 (CHMP3)
caps the filament and Vps2
(CHMP2A-B) initiates its
disassembly by the ATPase
Vps4 (Saksena et al., 2009).
Altogether, there are 11
human CHMP proteins, and
all are known to be required
for normal cell division (Moritaet al., 2010). However, their role in HIV-1
budding has remained unclear until now.
HIV-1 Gag engages ESCRT-III indi-
rectly via so-called late assembly
domains that constitute binding sites for
TSG101 and ALIX (Bieniasz, 2006).
TSG101 is a component of ESCRT-I,
which couples to ESCRT-III via the central
ESCRT-II complex in the pathway (Sak-
sena et al., 2007). In contrast, ALIX inter-
acts directly with ESCRT-III component
CHMP4 (Hurley and Hanson, 2010).
Although the binding site for TSG101/
ESCRT-I is crucial for HIV-1 budding,
ESCRT-II is dispensable (Langelier
et al., 2006). Thus, how HIV-1 triggers
ESCRT-III assembly via ESCRT-I remains
a mystery. It is equally mysterious that not
all of the core components of ESCRT-III
are required for HIV-1 release. Indeed, it
appears that CHMP6 is entirely dispens-
able, in spite of its crucial role in the poly-
merization of ESCRT-III on endosomal
membranes (Langelier et al., 2006). This
poses the question of which ESCRT-III
components constitute the minimal mem-
brane fission machinery and which regu-
late process-specific functions.
Morita et al. (2011) have now employed
a systematic siRNA knockdown screen to
determine the minimal requirements for
ESCRT-III function at the HIV-1 budding
site. The essence of their findings is that
only CHMP4 and CHMP2 (either A or B)
must be present at the budding site to
facilitate efficient HIV-1 release. A particu-
larly unexpected finding was that humanCHMP3 is dispensable for HIV-1 budding,
even though the role of its yeast counter-
part in MVB formation would suggest that
CHMP3 serves as an essential bridge
between CHMP4 and CHMP2 (Saksena
et al., 2007). However, it turns out that
human CHMP4 and CHMP2 can interact
directly, bypassing the need for an inter-
mediary. Intriguingly, the authors observe
that the lack of CHMP2 proteins causes
ring-like structures to appear within the
necks of arrested HIV-1 buds. This
suggests a model in which CHMP4
forms the rings, and CHMP2, together
with the associated ATPase VPS4, is
required to remodel the CHMP4 filament,
possibly into a dome, to induce mem-
brane constriction and subsequent dis-
assembly of the copolymer (Figure 1).
Overall, the picture that emerges is that
the ESCRT ingredients needed for HIV-1
budding are fundamentally different from
those required for yeast MVB biogenesis.
These findings are complemented by
two imaging studies that shed light on
the kinetics of ESCRT engagement. Using
total internal reflection fluorescence
microscopy, Jouvenet et al. (2011)
observed that ESCRT-III components
and VPS4 associate with HIV-1 assembly
sites only transiently, most often in a
single pulse. Notably, the appearance of
ESCRT-III primarily after Gag saturation
at the budding site, marking the end of
the assembly process, argues against
a role for ESCRT-III in HIV-1 assembly.
Although the late domain interactionCell Host & Microbe 9, March 17partners TSG101 and ALIX
could not be detected at
HIV-1 budding sites, most
likely due to low abundance,
ESCRT-III recruitment was
strictly late-domain-depen-
dent, as expected. The
dynamics of ALIX recruitment
could be examined after re-
placing HIV-1 with equine
infectious anemia virus Gag,
which has a higher affinity for
ALIX. Interestingly, unlike
ESCRT-III, ALIX accumulates
at budding sites with the
same dynamics as Gag.
Together, these results
suggest a model in which
early-acting factors such as
ALIX progressively accumu-
late to a threshold level that
then triggers the rapid andtransient polymerization of ESCRT-III at
viral bud necks.
The imaging results also shed new light
on the function of VPS4, which is required
for HIV-1 budding, but nevertheless could
merely play an indirect role because it is
needed to recycle ESCRT-III (Hurley and
Hanson, 2010; Saksena et al., 2007). In
the latter case, dominant-negative VPS4
would be expected to cause a shortage
of ESCRT-III components at HIV-1
budding sites. On the contrary, it turns
out that dominant-negative VPS4
increases the localization of CHMP
proteins to sites of HIV-1 assembly. This
indicates that ESCRTs are in place but
fail to catalyze membrane fission and
argues for a model where the ATPase
activity of VPS4 plays an active role in
the scission reaction.
This latter scenario is reinforced by the
live imaging study of Baumga¨rtel et al.
(2011), which corroborates that VPS4
activity induces HIV-1 release. In agree-
ment with Jouvenet and colleagues, these
authors also observed intense bursts of
VPS4 recruitment at HIV-1 budding sites
that occurred predominantly after the
completion of HIV-1 assembly. Because
the appearance of VPS4 bursts lasted
less than a minute and generally occurred
before particle release, Baumga¨rtel and
colleagues also propose that VPS4 is
directly involved in the detachment of
HIV-1 from the plasma membrane. The
kinetics of transient VPS4 recruitment
prior to virus release has important, 2011 ª2011 Elsevier Inc. 173
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Previewsimplications for ESCRT-III function and
indicates that VPS4 activity is required
for membrane scission in vivo. In contrast,
in vitro experiments with giant unilamellar
vesicles and yeast ESCRT pathway
components showed that abscission of
vesicles depended only on ESCRT-III,
but not on Vps4 (Hurley and Hanson,
2010).
Several models have been brought
forward for ESCRT-III function, including
the stepwise removal of protomers from
circular ESCRT-III polymers leading to
membrane constriction and dome-like
ESCRT-III scaffolds promoting constric-
tion (Hurley and Hanson, 2010; Peel
et al., 2010). Baumga¨rtel and colleagues
suggest that the small number of VPS4
bursts per budding site and the delay
between those bursts and particle release
argue against a stepwise removal of
ESCRT-III components. The short resi-
dency of a few VPS4 dodecamers at the
budding site might be more consistent
with the dome-shaped ESCRT-III model
(Lata et al., 2008) supported by computa-
tional modeling (Fabrikant et al., 2009).
In this latter scenario, dodecameric174 Cell Host & Microbe 9, March 17, 2011 ªVPS4 might reinforce the ESCRT-III poly-
mer (Fabrikant et al., 2009), and/or the
ESCRT-III/VPS4 scaffold might keep
the membrane in a stressed state where
abrupt, ATPase activity-driven removal
might facilitate spontaneous fission (Peel
et al., 2010). Thus, the new findings re-
ported in these three papers will further
spark the hunt to define the minimal
mammalian ESCRT-III/VPS4 membrane
fission complex.ACKNOWLEDGMENTS
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While a polysaccharide capsule is known to be important for preventing phagocytosis of the humanpathogen
Cryptococcus neoformans, other antiphagocytic pathways have been generally elusive. Now, a capsule-
independent pathway has been identified that preventsmacrophages from ingesting the fungus, contributing
to evasion of the host immune response.Among the human fungal pathogens,
Cryptococcus neoformans is unique in its
ability to evade phagocytosis by macro-
phages. In a comprehensive analysis of
genes involved in preventing phagocy-
tosis, Chun et al. identify a pathway
responsible for aiding C. neoformans inevading the host immune response that
has implications for how all microbes
avoid immune detection (Chun et al.,
2011). In the case ofC. neoformans, inves-
tigating mechanisms of pathogenesis
is paramount because C. neoformans
is found worldwide and causes over600,000 deaths each year (Park et al.,
2009). People acquire C. neoformans
by inhaling infectious particles from the
environment and generally suffer no
apparent ill effects. However, immuno-
compromised individuals are susceptible
to developing severe, life-threatening
